NXTC (NextCure, Inc.) Stock Financials & Earnings | Market Cap Arena

NXTC (NextCure, Inc.) Stock Financials & Earnings | Market Cap Arena

NXTCNextCure, Inc.

Mkt Cap$36M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$56M

EPS (TTM)-$21.90

Free Cash Flow (TTM)-$50M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$17M
Q2 23	$0	$0	-$19M
Q3 23	$0	$0	-$16M
Q4 23	$0	$0	-$16M
Q1 24	$0	$0	-$18M
Q2 24	$0	-$701K	-$16M
Q3 24	$0	$0	-$12M
Q4 24	$0	$0	-$12M
Q1 25	$0	$0	-$12M
Q2 25	$0	$0	-$27M
Q3 25	$0	$0	-$9M
Q4 25	$0	-$365K	-$10M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$15M	-$15M
Q2 23	-$15M	-$15M
Q3 23	-$13M	-$13M
Q4 23	-$11M	-$11M
Q1 24	-$13M	-$13M
Q2 24	-$10M	-$10M
Q3 24	-$11M	-$12M
Q4 24	-$7M	-$7M
Q1 25	-$13M	-$13M
Q2 25	-$23M	-$23M
Q3 25	-$6M	-$6M
Q4 25	-$8M	-$8M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$248K
Q2 23	$280K
Q3 23	$279K
Q4 23	$13K
Q1 24	$37K
Q2 24	$301K
Q3 24	$170K
Q4 24	$34K
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-17.8%
Q2 23	—	+5.7%
Q3 23	—	-18.8%
Q4 23	—	-11.1%
Q1 24	—	+7.2%
Q2 24	—	-13.9%
Q3 24	—	-20.0%
Q4 24	—	-21.1%
Q1 25	—	-36.5%
Q2 25	—	+65.5%
Q3 25	—	-28.4%
Q4 25	—	-21.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	—
Q2 23	$2M	—
Q3 23	$2M	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$2M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$1M	—
Q2 25	$588K	—
Q3 25	$600K	—
Q4 25	$435K	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$12M	$5M	—
Q2 23	$13M	$6M	—
Q3 23	$11M	$5M	—
Q4 23	$12M	$4M	—
Q1 24	$11M	$4M	—
Q2 24	$12M	$4M	—
Q3 24	$9M	$4M	—
Q4 24	$9M	$4M	—
Q1 25	$8M	$4M	—
Q2 25	$24M	$3M	—
Q3 25	$6M	$3M	—
Q4 25	$6M	—	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$30M	$116M	$145M
Q2 23	$22M	$109M	$131M
Q3 23	$20M	$99M	$118M
Q4 23	$13M	$95M	$108M
Q1 24	$18M	$78M	$96M
Q2 24	$21M	$66M	$86M
Q3 24	$28M	$48M	$75M
Q4 24	$28M	$41M	$69M
Q1 25	$22M	$34M	$56M
Q2 25	$5M	$30M	$35M
Q3 25	$7M	$22M	$29M
Q4 25	$26M	$16M	$42M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	2M	+0.0%
Q2 23	2M	+0.2%
Q3 23	2M	+0.0%
Q4 23	2M	+0.3%
Q1 24	2M	-0.0%
Q2 24	2M	+0.2%
Q3 24	2M	+0.0%
Q4 24	2M	+0.1%
Q1 25	2M	+0.0%
Q2 25	2M	+1.8%
Q3 25	3M	+12.7%
Q4 25	4M	+31.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 17	—	—
FY 18	—	—
FY 19	$92K	69
FY 20	$249K	90
FY 21	$0	87
FY 22	$0	99
FY 23	$0	82
FY 24	$0	43
FY 25	$0	200K